Quinidine in the treatment of KCNT1-positive epilepsies.

导出 OA

翻译打印收藏纠错

第一作者： Mohamad A,Mikati

第一单位： Division of Pediatric Neurology, Department of Pediatrics and Department of Neurobiology, Duke University School of Medicine, Durham, NC.

作者： Mohamad A,Mikati ^[1] ; Yong-Hui,Jiang ^[2] ; Michael,Carboni ^[3] ; Vandana,Shashi ^[2] ; Slave,Petrovski ^[4] ; Rebecca,Spillmann ^[4] ; Carol J,Milligan ^[5] ; Melody,Li ^[5] ; Annette,Grefe ^[6] ; Allyn,McConkie ^[2] ; Samuel,Berkovic ^[7] ; Ingrid,Scheffer ^[7] ; Saul,Mullen ^[5] ; Melanie,Bonner ^[8] ; Steven,Petrou ^[7] ; David,Goldstein ^[4]

作者单位： Division of Pediatric Neurology, Department of Pediatrics and Department of Neurobiology, Duke University School of Medicine, Durham, NC. ^[1] Division of Medical Genetics, Department of Pediatrics, Duke University School of Medicine, Durham, NC. ^[2] Division of Cardiology, Department of Pediatrics, Duke University School of Medicine, Durham, NC. ^[3] Center for Human Genome Variation, Duke University School of Medicine, Durham, NC. ^[4] Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia. ^[5] Department of Neurology, Wake Forest University, Winston-Salem, NC. ^[6] Epilepsy Research Centre, Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia. ^[7] Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC. ^[8]